An open-label, multicentric, phase I study with expansion cohorts, evaluating the safety and the efficacy of combination of atezolizumab, tiragolumab and stereotactic body radiation therapy in patients with metastatic multiorgan cancer

Metastatic bladder cancer : For expansion cohort, Metastatic head and neck carcinoma : For expansion cohort, Metastatic non small cell lung cancer (Phase I and expansion cohorts), Metastatic renal cell carcinoma : For expansion cohort

No related papers found yet.

None listed

France